Harmony Biosciences Holdings, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
  • Harmony Biosciences Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.4M, a 43.9% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.7M, a 39.2% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $31.2M, a 16% increase from 2022.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26.9M, a 67.1% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.1M, a 210% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $41.7M $11.4M +$3.49M +43.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $38.2M $11M +$3.17M +40.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $35.1M $10.4M +$3.87M +59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $31.2M $8.9M +$1.22M +16% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $30M $7.96M +$990K +14.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $29M $7.79M +$422K +5.73% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $28.6M $6.56M +$1.67M +34% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $26.9M $7.67M +$3.29M +75% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $23.6M $6.97M +$2.3M +49.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $21.3M $7.37M +$3.56M +93.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $17.8M $4.9M +$1.65M +50.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $16.1M $4.38M +$1.46M +49.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $14.6M $4.66M +$3.33M +251% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $11.3M $3.81M +$3.35M +726% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $7.97M $3.25M +$2.78M +584% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $5.19M $2.92M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $1.33M +$923K +227% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $461K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $475K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $407K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.